Maraviroc

Product NDC
42858-246
Requested package NDC
42858-246-06
11-digit product format
428580246
Labeler code
42858
Product ID
42858-246_7f97db4c-6c65-4056-b301-53feac86d8f4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Maraviroc
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Rhodes Pharmaceuticals LLC
Application
ANDA216143
Marketing category
ANDA
Marketing start
2026-09-30
Substance
MARAVIROC
Active strength
150 mg/1
Pharmacologic classes
CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A216143-001MARAVIROCMARAVIROC150MGTABLET / ORALAB2025-11-04
A216143-002MARAVIROCMARAVIROC300MGTABLET / ORALAB2025-11-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A216143-001AB
A216143-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A216143-001MARAVIROC150MGTABLET / ORALAB2025-11-04d4dbc9d85df4…
2026-11-14 07:37:172026-10A216143-002MARAVIROC300MGTABLET / ORALAB2025-11-04d4dbc9d85df4…
2026-10-15 13:18:302026-09A216143-001MARAVIROC150MGTABLET / ORALAB2025-11-04c2088c7a36db…
2026-10-15 13:18:302026-09A216143-002MARAVIROC300MGTABLET / ORALAB2025-11-04c2088c7a36db…
2026-09-14 22:38:342026-08A216143-001MARAVIROC150MGTABLET / ORAL2025-11-0484e616aacf4f…
2026-09-14 22:38:342026-08A216143-002MARAVIROC300MGTABLET / ORAL2025-11-0484e616aacf4f…
2026-08-18 06:07:402026-07A216143-001MARAVIROC150MGTABLET / ORAL2025-11-04caaa826d4ba7…
2026-08-18 06:07:402026-07A216143-002MARAVIROC300MGTABLET / ORAL2025-11-04caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A216143-001MARAVIROC150MGTABLET / ORALAB2025-11-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02A216143-002MARAVIROC300MGTABLET / ORALAB2025-11-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216143-001MARAVIROC150MGTABLET / ORALAB2025-11-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216143-002MARAVIROC300MGTABLET / ORALAB2025-11-0431067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216143-001MARAVIROC150MGTABLET / ORAL2025-11-04a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216143-002MARAVIROC300MGTABLET / ORAL2025-11-04a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A216143-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A216143-002AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A216143-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A216143-002AB1c2088c7a36db…
2026-02-19 14:30 UTC2026-02A216143-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A216143-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216143-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216143-002AB131067a03dcf5…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Maraviroc
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
MARAVIROC150 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
MD6P741W8AInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
728223Internal RxNorm lookup
728225Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
c35f72dc-d90e-43f8-9899-f7d1da89460dAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MaravirocMARAVIROCRhodes Pharmaceuticals LLCc35f72dc-d90e-43f8-9899-f7d1da89460d2026-09-30Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 216143
application number: ANDA216143
ndc (package): 42858-246-06
ndc (product): 42858-246
ndc11 (package): 42858024606

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
42858-246-064285802460660 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42858-246-06) 2026-09-30NoNoCurrent